NCT00218374View on ClinicalTrials.gov

Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
HyperalgesiaOpioid-Related Disorders
Interventions
DRUG

Gabapentin

Gabapentin initiated up to a daily dose of 2400mg PO x 5 weeks

Trial Locations (1)

90024

University of California, Los Angeles, Los Angeles

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00218374 - Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia | Biotech Hunter | Biotech Hunter